Plenful Launched Automation for HRSA 340B Rebate Pilot
Enterprise health systems are adopting new software to manage mandatory post-purchase rebate reconciliations.
Updated on Oct. 6, 2026 in Healthcare
Live Poll
Do you believe automated software solutions improve financial efficiency for large health systems?
Plenful has released a software platform to automate rebate submissions for the upcoming HRSA 340B Rebate Model Pilot. More than 30 enterprise health systems have already contracted for the tool to manage compliance before the program goes live on January 1, 2027.
Why it matters
The HRSA pilot shifts the 340B program from upfront discounts to a post-purchase rebate model, creating complex new data submission requirements. Automated tracking is becoming a business necessity as manual spreadsheet methods prove unsustainable for the pilot's rigorous daily reporting standards.
The pilot encompasses $5.5 billion in annual drug volume with $2.75 billion in savings at stake, representing roughly 5.5% of the total $100 billion 340B market seen in 2025. More than 30 enterprise health systems have already secured software contracts to manage these requirements.
The players
Plenful
A healthcare technology company providing automated reconciliation software for hospital pharmacy rebate programs.
HRSA
The Health Resources and Services Administration agency responsible for overseeing the 340B drug discount program for healthcare entities.
The details
The platform automates the identification of rebate-eligible claims and handles daily submissions through the Beacon portal. It flags missing data elements in real-time, replacing manual tracking systems. The software is designed to reconcile complex claim-level data, which is expected to become the operational standard once the HRSA program officially begins.
Timeline
Covered entities made $100 billion in 340B purchases during 2025.
Medicare's Drug Price Negotiation Program includes eligibility criteria for 2026 and 2027.
The HRSA 340B Rebate Model Pilot begins on January 1, 2027.
Market Landscape
This move reflects the industry's transition toward the HRSA 340B Drug Pricing Program's new regulatory requirements. It follows a broader trend of digitizing manual pharmaceutical billing to meet stringent federal data reconciliation standards.
Operators managing 340B programs should evaluate whether their current manual reconciliation processes can handle daily claim-level submissions. Budgeting for compliance software is now a critical step for systems participating in the upcoming rebate-model pilot.
The takeaway
The move to a rebate-based 340B model shifts the administrative burden from simple discounting to complex, continuous data validation. Operators should verify their internal data sets now to ensure they are ready for the January 1, 2027, pilot launch date.
Further reading
For more on industry shifts, visit our section on Healthcare.
Live Poll
Do you believe automated software solutions improve financial efficiency for large health systems?
